ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 199,71
0,00%
Dow Jones
43 191,24
-1,48%
DAX
23 147,02
2,90%
Brent Oil
71,025
-0,53%
Bitcoin
83 567,86
-2,93%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Intersect ENT Inc (XENT)

  7. Intersect ENT Inc (XENT) Actualités

XENT

Intersect ENT (XENT)

Intersect ENT Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:XENT
DateHeureSourceTitreSymboleSociété
10/02/202322h23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XENTIntersect ENT Inc
12/09/202219h11Edgar (US Regulatory)Withdrawal of a Registration Statement Withdrawal Request (rw Wd)NASDAQ:XENTIntersect ENT Inc
19/05/202222h50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:XENTIntersect ENT Inc
18/05/202212h07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:XENTIntersect ENT Inc
17/05/202200h58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XENTIntersect ENT Inc
13/05/202215h08Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:XENTIntersect ENT Inc
13/05/202215h01Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:XENTIntersect ENT Inc
13/05/202214h59Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:XENTIntersect ENT Inc
09/05/202223h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XENTIntersect ENT Inc
04/05/202222h43Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XENTIntersect ENT Inc
29/04/202222h04Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:XENTIntersect ENT Inc
08/03/202222h14Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XENTIntersect ENT Inc
08/03/202222h04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XENTIntersect ENT Inc
31/01/202220h35Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XENTIntersect ENT Inc
25/01/202213h00Business WireReal-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource UtilizationNASDAQ:XENTIntersect ENT Inc
02/11/202121h15Business WireIntersect ENT Reports Third Quarter 2021 Financial ResultsNASDAQ:XENTIntersect ENT Inc
28/10/202113h00Business WireFirst Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in EuropeNASDAQ:XENTIntersect ENT Inc
30/09/202122h02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XENTIntersect ENT Inc
19/08/202114h47Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:XENTIntersect ENT Inc
09/08/202120h47PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Intersect ENT, Inc.NASDAQ:XENTIntersect ENT Inc
09/08/202117h07TipRanksMedtronic Gains Investor Confidence with Intersect BuyoutNASDAQ:XENTIntersect ENT Inc
09/08/202111h55TipRanksIntersect ENT’s Q2 Results Miss Expectations; Shares Jump on Acquisition NewsNASDAQ:XENTIntersect ENT Inc
06/08/202116h24Dow Jones NewsIntersect ENT Shares Rise on Medtronic Takeover DealNASDAQ:XENTIntersect ENT Inc
06/08/202113h48Dow Jones NewsMedtronic to Buy Intersect ENT for $28.25/ShareNASDAQ:XENTIntersect ENT Inc
06/08/202113h15Business WireIntersect ENT Reports Second Quarter 2021 Financial ResultsNASDAQ:XENTIntersect ENT Inc
06/08/202113h00PR Newswire (US)Medtronic to Acquire Intersect ENTNASDAQ:XENTIntersect ENT Inc
26/07/202113h00Business WireU.S Nationwide Commercial Availability of the VenSure™ Balloon Sinus Dilation System and Cube™ Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic RhinosinusitisNASDAQ:XENTIntersect ENT Inc
23/07/202114h00Business WireIntersect ENT to Report Second Quarter 2021 Financial Results on August 6NASDAQ:XENTIntersect ENT Inc
22/07/202122h05Business WireIntersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term LoanNASDAQ:XENTIntersect ENT Inc
20/05/202113h46Business WireIntersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus...NASDAQ:XENTIntersect ENT Inc
 Showing the most relevant articles for your search:NASDAQ:XENT

Dernières Valeurs Consultées

EU
MC
Lvmh Moet Hennessy Louis...
EU
LR
Legrand
NASDAQ
AAPL
Apple
EU
SGO
Cie de SaintGobain
EU
RI
Pernod Ricard
EU
CS
Axa
NYSE
KO
Coca Cola
COIN
ETHUSD
Ethereum
EU
AF
Air FranceKLM
EU
RNO
Renault
EU
ACA
Credit Agricole
EU
ORA
Orange
SPI
SP500
S&P 500
EU
PX1
CAC 40
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces